RhumbLine Advisers
MTEM

RhumbLine Advisers’s Molecular Templates, Inc. MTEM Stock Holding History

RhumbLine Advisers’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-56
Closed -$207 – 4311
2023
Q4 		$207 Hold
56
– – ﹤0.01% 4235
2023
Q3 		$353 Sell
56
-1
-2% -$8 ﹤0.01% 4251
2023
Q2 		$408 Buy
+57
New +$390 ﹤0.01% 4327
2022
Q2 		– Sell
-2,213
Closed -$115K – 3298
2022
Q1 		$115K Buy
2,213
+76
+4% +$3.36K ﹤0.01% 2862
2021
Q4 		$126K Sell
2,137
-30
-1% -$2.25K ﹤0.01% 2912
2021
Q3 		$218K Buy
2,167
+89
+4% +$9.18K ﹤0.01% 2879
2021
Q2 		$244K Buy
2,078
+172
+9% +$22.5K ﹤0.01% 2865
2021
Q1 		$361K Sell
1,906
-131
-6% -$23K ﹤0.01% 2634
2020
Q4 		$287K Buy
2,037
+139
+7% +$20.5K ﹤0.01% 2687
2020
Q3 		$311K Sell
1,898
-243
-11% -$43.2K ﹤0.01% 2507
2020
Q2 		$443K Buy
2,141
+607
+40% +$141K ﹤0.01% 2403
2020
Q1 		$306K Buy
1,534
+213
+16% +$46.6K ﹤0.01% 2394
2019
Q4 		$277K Buy
1,321
+11
+0.8% +$1.58K ﹤0.01% 2635
2019
Q3 		$129K Buy
1,310
+50
+4% +$4.66K ﹤0.01% 2846
2019
Q2 		$158K Buy
1,260
+311
+33% +$33.8K ﹤0.01% 2846
2019
Q1 		$83K Buy
949
+74
+8% +$5.42K ﹤0.01% 2883
2018
Q4 		$53K Buy
+875
New +$61.1K ﹤0.01% 2939
2016
Q2 		– Sell
-396
Closed -$30K – 3034
2016
Q1 		$30K Hold
396
– – ﹤0.01% 2978
2015
Q4 		$31K Buy
396
+36
+10% +$17.7K ﹤0.01% 3015
2015
Q3 		$242K Buy
360
+13
+4% +$9.25K ﹤0.01% 2679
2015
Q2 		$231K Sell
347
-7
-2% -$4.63K ﹤0.01% 2805
2015
Q1 		$237K Buy
354
+86
+32% +$56.6K ﹤0.01% 2746
2014
Q4 		$141K Buy
268
+9
+3% +$4.5K ﹤0.01% 2899
2014
Q3 		$154K Hold
259
– – ﹤0.01% 2848
2014
Q2 		$169K Buy
259
+19
+8% +$12.6K ﹤0.01% 2894
2014
Q1 		$189K Sell
240
-14
-6% -$11.4K ﹤0.01% 2790
2013
Q4 		$196K Sell
254
-10
-4% -$7.54K ﹤0.01% 2827
2013
Q3 		$202K Buy
264
+7
+3% +$5.75K ﹤0.01% 2779
2013
Q2 		$223K Buy
+257
New +$217K ﹤0.01% 2908

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RhumbLine Advisers's MTEM Position: Q1 2024 in Review

RhumbLine Advisers sold out of Molecular Templates, Inc. (MTEM) in Q1 2024, closing a stake of 56 shares — an estimated $207 sold.

RhumbLine Advisers first reported a position in MTEM in Q2 2013 and held it in 29 quarters. The position peaked at $443K in Q2 2020. 29 funds tracked by Wall St. Rank hold MTEM as of Q1 2024.

  • RhumbLine Advisers reported no remaining Molecular Templates, Inc. position as of Q1 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 56 Molecular Templates, Inc. shares in Q1 2024, an estimated $207.
  • RhumbLine Advisers first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 29 quarters.
  • RhumbLine Advisers's Molecular Templates, Inc. position peaked at $443K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2024.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.